NHS saved £324 million by switching to biosimilars and genericsThe UK’s national healthcare provider saved £324 million by switching its patients to “better value” biosimilar and generic Share XNHS saved £324 million by switching to biosimilars and genericshttps://pharmaphorum.com/news/nhs-saved-millions-switching-biosimilars/
Future of NHS is ‘precarious,’ warns watchdogThe independent watchdog for health and social care in England says the country’s NHS faces a ‘precarious’ future Share XFuture of NHS is ‘precarious,’ warns watchdoghttps://pharmaphorum.com/news/future-nhs-precarious-warns-watchdog/
